Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: A cross-sectional study of methods to communicate risk in primary care

Author(s):

J. G. McIntosh, S. Saya, J. Minshall, A. Bickerstaffe, N. Hewabandu, A. Qama, J. D. Emery

Details:

British Journal of General Practice, Volume 69, Issue 689, 2019-01-01

Article Link: Click here

Affiliations:

• University of Cambridge
• The Peter Doherty Institute for Infection and Immunity
• Western Health
• Centre for Epidemiology and Biostatistics
• University of Melbourne